Exact Mass: 389.0711

Exact Mass Matches: 389.0711

Found 177 metabolites which its exact mass value is equals to given mass value 389.0711, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Progoitrin

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (3R)-3-hydroxy-N-sulfooxy-pent-4-enimidothioate

C11H19NO10S2 (389.045)


Progoitrin is found in brassicas. Progoitrin is present in red cabbage, Brussel sprouts, savoy cabbage, Brassica napus (rape seed) and other Brassica species Progoitrin is a biochemical that is found in some food, which is inactive but after ingestion is converted to goitrin. Goitrin decrease the thyroid hormone production. 2-Hydroxy-3-butenyl glucosinolate is a natural product found in Zilla spinosa, Brassica incana, and other organisms with data available. Present in red cabbage, Brussel sprouts, savoy cabbage, Brassica napus (rape seed) and other Brassica subspecies Progoitrin is the stereoisomer of xi-progoitrin that has R at the carbon bearing the allylic hydroxy group. It has a role as a plant metabolite. It is a conjugate acid of a progoitrin(1-). Progoitrin is a natural product found in Isatis tinctoria and Brassica oleracea with data available. Acquisition and generation of the data is financially supported in part by CREST/JST. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

Acetyl adenylate

[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] acetate

C12H16N5O8P (389.0736)


Acetyl adenylate is an intermediate in acetyl-CoA synthesis. It is converted from acetate via the enzyme acetyl-CoA synthetase. It is involved in the non-enzymatic acetylation of histones in chromatin (PMID:8619849). In microbes acetyl adenylate also plays a role in the direction of flagellar rotation (PMID:2901103) [HMDB] Acetyl adenylate is an intermediate in acetyl-CoA synthesis. It is converted from acetate via the enzyme acetyl-CoA synthetase. It is involved in the non-enzymatic acetylation of histones in chromatin (PMID:8619849). In microbes acetyl adenylate also plays a role in the direction of flagellar rotation (PMID:2901103).

   

N-Acetylneuraminate 9-phosphate

(4R,5S,6S)-6-[(1R,2R)-1,2-dihydroxy-3-(phosphonooxy)propyl]-5-acetamido-2,4-dihydroxyoxane-2-carboxylic acid

C11H20NO12P (389.0723)


N-Acetylneuraminate 9-phosphate is an intermediate in Aminosugars metabolism. N-Acetylneuraminate 9-phosphate is the 4th to last step in the synthesis of colominate and is converted from N-Acetyl-D-mannosamine-6-phosphate via the enzyme N-Acylneuraminate-9-phosphate synthase (EC 2.5.1.57). It is then converted to N-Acetylneuraminate via the enzyme N-acylneuraminate-9-phosphatase(EC 3.1.3.29). [HMDB] N-Acetylneuraminate 9-phosphate is an intermediate in Aminosugars metabolism. N-Acetylneuraminate 9-phosphate is the 4th to last step in the synthesis of colominate and is converted from N-Acetyl-D-mannosamine-6-phosphate via the enzyme N-Acylneuraminate-9-phosphate synthase (EC 2.5.1.57). It is then converted to N-Acetylneuraminate via the enzyme N-acylneuraminate-9-phosphatase(EC 3.1.3.29).

   

Cefprozil

(6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C18H19N3O5S (389.1045)


Cefprozil is only found in individuals that have used or taken this drug. It is a cephalosporin antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections.Cefprozil, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefprozil interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Cyclothiazide

3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide

C14H16ClN3O4S2 (389.0271)


As a diuretic, cyclothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like cyclothiazide also inhibit sodium ion transport across the renal tubular epithelium through binding to the thiazide sensitive sodium-chloride transporter. This results in an increase in potassium excretion via the sodium-potassium exchange mechanism. The antihypertensive mechanism of cyclothiazide is less well understood although it may be mediated through its action on carbonic anhydrases in the smooth muscle or through its action on the large-conductance calcium-activated potassium (KCa) channel, also found in the smooth muscle. Cyclothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D01256 Cyclothiazide, a positive allosteric modulator of AMPA receptors, is used frequently to block the desensitization of both native and heterologously expressed AMPA receptors. Cyclothiazide is known to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current[1].

   

2-Methylbutyl glucosinolate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 3-methyl-N-sulfooxy-pentanimidothioate

C12H23NO9S2 (389.0814)


   

N-Acetylneuraminic acid 9-phosphate

(4S,5R,6R)-6-[(1R,2R)-1,2-dihydroxy-3-(phosphonooxy)propyl]-5-acetamido-2,4-dihydroxyoxane-2-carboxylic acid

C11H20NO12P (389.0723)


N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772) [HMDB] N-Acetylneuraminic acid 9-phosphate is an intermediate in the synthesis of Acetylneuraminic acid, a process occurring in the cytosolic fraction by the human enzyme N-Acetylneuraminic acid 9-phosphate (Neu5Ac 9-P) synthase, that catalyzes the synthesis of N-Acetylneuraminic acid 9-phosphate, in a reaction by the mechanism of aldol condensation of phosphoenolpyruvate (PEP) with sugar substrates, ManNAc-6-P (N-acetylmannosamine 6-phosphate) or Man-6-P (mannose 6-phosphate). N-Acetylneuraminic acid 9-phosphate is converted to N-Acetylneuraminic acid by the enzyme N-acetylneuraminate-9-phosphate phosphatase. (PMID: 16503877, 6093772).

   

3-Methylbutyl glucosinolate

{[(e)-(4-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}pentylidene)amino]oxy}sulphonic acid

C12H23NO9S2 (389.0814)


3-Methylbutyl glucosinolate is found in brassicas. 3-Methylbutyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 3-Methylbutyl glucosinolate is found in horseradish and brassicas.

   

Pentyl glucosinolate

{[(e)-(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}hexylidene)amino]oxy}sulphonic acid

C12H23NO9S2 (389.0814)


Present in radish (Raphanus sativus) and in kohlrabi aroma. Pentyl glucosinolate is found in horseradish, brassicas, and radish. Pentyl glucosinolate is found in brassicas. Pentyl glucosinolate is present in radish (Raphanus sativus) and in kohlrabi aroma.

   

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

C19H14F3N3O3 (389.0987)


   

2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl isothiocyanate

[3,4,5-Tris(acetyloxy)-6-isothiocyanatooxan-2-yl]methyl acetic acid

C15H19NO9S (389.078)


   

3',6'-Dihydroxy-6-isothiocyanatospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one

3,6-Dihydroxy-6-isothiocyanatospiro[isobenzofuran-1(3H),9-[9H]xanthen]-3-one

C21H11NO5S (389.0358)


   

Fluorescein-5-isothiocyanate

3,6-Dihydroxy-5-isothiocyanatospiro(isobenzofuran-1(3H),9-(9H)xanthen)-3-one

C21H11NO5S (389.0358)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

Fluoresceine isothiocyanate

3,6-dihydroxy-8-isothiocyanato-3H-spiro[2-benzofuran-1,9-xanthene]-3-one

C21H11NO5S (389.0358)


   

Indibulin

2-{1-[(4-chlorophenyl)methyl]-1H-indol-3-yl}-2-oxo-N-(pyridin-4-yl)acetamide

C22H16ClN3O2 (389.0931)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

monophospho-n-acetylneuraminic acid

5-acetamido-4-hydroxy-2-(phosphonooxy)-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid

C11H20NO12P (389.0723)


   

Taisho

3-[({2-[(4-carbamimidoylbenzoyl)imino]-3,4-dimethyl-2,3-dihydro-1,3-thiazol-5-yl}(hydroxy)methylidene)amino]propanoate

C17H19N5O4S (389.1158)


   

Brisoral

7-{[2-amino-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C18H19N3O5S (389.1045)


   

1-Methylbutyl glucosinolate

1-Methylbutyl glucosinolate

C12H23NO9S2 (389.0814)


   
   

1-Thio-beta-D-glucopyranoside 1-[4-methyl-N-(sulfooxy)pentanimidate]

1-Thio-beta-D-glucopyranoside 1-[4-methyl-N-(sulfooxy)pentanimidate]

C12H23NO9S2 (389.0814)


   

epiprogoitrin

2(S)-2-Hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.045)


   

Azoxystrobin acid

Azoxystrobin acid

C21H15N3O5 (389.1012)


An aryloxypyrimidine having a 4,6-diphenoxypyrimidine skeleton in which one of the phenyl rings is cyano-substituted at C-2 and the other carries a 1-carboxy-2-methoxyethenyl substituent, also at C-2. It is a metabolite of the fungicidal agrochemical azoxystrobin. CONFIDENCE standard compound; INTERNAL_ID 2031

   
   

Maybridge1_003736

Maybridge1_003736

C24H20ClNO2 (389.1182)


   
   
   

Celastramycin A

(3-chloro-5-hexyl-2,6-dihydroxyphenyl)(4,5-dichloro-1H-pyrrol-3-yl)-methanone

C17H18Cl3NO3 (389.0352)


   
   

Benzisoxazole Hsp90 Inhibitor

Benzisoxazole Hsp90 Inhibitor

C19H20ClN3O4 (389.1142)


   

CAY10566

3-[4-(2-chloro-5-fluorophenoxy)-1-piperidinyl]-6-(5-methyl-1,3,4-oxadiazol-2-yl)-pyridazine

C18H17ClFN5O2 (389.1055)


CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively. CAY10566 also shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM)[1][2].

   

Natural Yellow 18

16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride;hydrate

C20H20ClNO5 (389.103)


Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].

   

Azoxystrobin (free acid)

Azoxystrobin (free acid)

C21H15N3O5 (389.1012)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 2734

   

epi-Progoitrin

(2S)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.045)


The stereoisomer of xi-progoitrin that has S at the carbon bearing the allylic hydroxy group. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

progoitrin

(2R)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.045)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

(2S)-2-Hydroxybut-3-enylglucosinolate

(2S)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.045)


   

(2R)-2-Hydroxybut-3-enylglucosinolate

(2R)-2-Hydroxybut-3-enylglucosinolate

C11H19NO10S2 (389.045)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

(2R)-2-Hydroxy-3-butenyl glucosinolate

(2R)-2-Hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.045)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

(S)-2-hydroxy-3-butenyl glucosinolate

(S)-2-hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.045)


   

(2R)-2-Hydroxy-3-Butenylglucosinolate

(2R)-2-Hydroxy-3-Butenylglucosinolate

C11H19NO10S2 (389.045)


Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   
   

cyclothiazide

cyclothiazide

C14H16ClN3O4S2 (389.0271)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Same as: D01256 Cyclothiazide, a positive allosteric modulator of AMPA receptors, is used frequently to block the desensitization of both native and heterologously expressed AMPA receptors. Cyclothiazide is known to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current[1].

   

(2S)-2-Hydroxy-3-butenyl-glucosinolate

(2S)-2-Hydroxy-3-butenyl-glucosinolate

C11H19NO10S2 (389.045)


Annotation level-1

   
   
   

6-Hydroxyondansetron sulfate

6-Hydroxyondansetron sulfate

C18H19N3O5S (389.1045)


   

7-Hydroxyondansetron sulfate

7-Hydroxyondansetron sulfate

C18H19N3O5S (389.1045)


   

8-Hydroxyondansetron sulfate

8-Hydroxyondansetron sulfate

C18H19N3O5S (389.1045)


   
   
   
   

CAY10607

4-chloro-6-[5-[[2-(4-morpholinyl)ethyl]amino]-1,2-benzisoxazol-3-yl]-1,3-benzenediol

C19H20ClN3O4 (389.1142)


   

3-Methylbutyl glucosinolate

{[(E)-(4-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pentylidene)amino]oxy}sulfonic acid

C12H23NO9S2 (389.0814)


   

Pentyl glucosinolate

{[(1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hexylidene)amino]oxy}sulfonic acid

C12H23NO9S2 (389.0814)


   

3-(4-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(4-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H20BrNO4S (389.0296)


   
   
   

yttrium acetylacetonate

yttrium acetylacetonate

C15H24O6Y (389.0631)


   

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol,5b,6,7,12b,13,14-hexahydro-13-methyl-, hydrochloride (1:1), (5bR,6S,12bS)-

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridin-6-ol,5b,6,7,12b,13,14-hexahydro-13-methyl-, hydrochloride (1:1), (5bR,6S,12bS)-

C20H20ClNO5 (389.103)


   

METHYL-3-NITRO-4-(3,5-DICARBOXYMETHYL-PHENOXY)-BENZOATE

METHYL-3-NITRO-4-(3,5-DICARBOXYMETHYL-PHENOXY)-BENZOATE

C18H15NO9 (389.0747)


   

tert-butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate

tert-butyl 4-(5-iodopyridin-2-yl)piperazine-1-carboxylate

C14H20IN3O2 (389.06)


   

2-((tert-Butyldimethylsilyloxy)methyl)-6-iodofuro[3,2-b]pyridine

2-((tert-Butyldimethylsilyloxy)methyl)-6-iodofuro[3,2-b]pyridine

C14H20INO2Si (389.0308)


   

Ostarine D4

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-h ydroxy-2-methylpropanamide

C19H14F3N3O3 (389.0987)


   

Ostarine

Enobosarm

C19H14F3N3O3 (389.0987)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen

   

Thiazolidine, 2-(2-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(2-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C19H16ClNO2S2 (389.0311)


   

1-(5-bromofuran-2-yl)ethanone

1-(5-bromofuran-2-yl)ethanone

C15H20BrNO4S (389.0296)


   

(2,3,4,5,6-pentafluorophenyl) 6-(oxan-4-yloxy)pyridine-3-carboxylate

(2,3,4,5,6-pentafluorophenyl) 6-(oxan-4-yloxy)pyridine-3-carboxylate

C17H12F5NO4 (389.0686)


   

3-(2-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H20BrNO4S (389.0296)


   

3-(3-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(3-BROMO-BENZENESULFONYL)-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C15H20BrNO4S (389.0296)


   

Fluorescein 6-isothiocyanate

Fluorescein isothiocyanate (Spiro Form)

C21H11NO5S (389.0358)


   
   

protopine hydrochloride

protopine hydrochloride

C20H20ClNO5 (389.103)


   
   

2-Methyl-5-(tributylstannyl)thiazole

2-Methyl-5-(tributylstannyl)thiazole

C16H31NSSn (389.1199)


   

PIK-93

N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide

C14H16ClN3O4S2 (389.0271)


   

5-METHYL-2-(TRIBUTYLSTANNYL)THIAZOLE

5-METHYL-2-(TRIBUTYLSTANNYL)THIAZOLE

C16H31NSSn (389.1199)


   

Thiazolidine, 2-(4-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(4-chlorophenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C19H16ClNO2S2 (389.0311)


   

sodium 2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-8-methylquinoline-6-sulphonate

sodium 2-(2,3-dihydro-1,3-dioxo-1H-inden-2-yl)-8-methylquinoline-6-sulphonate

C19H12NNaO5S (389.0334)


   

fluorescein 5-isothiocyanate

fluorescein 5-isothiocyanate

C21H11NO5S (389.0358)


   

2-CHLORO-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

2-CHLORO-5-(6-METHOXY-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE

C18H16ClN3O5 (389.0778)


   

7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-2-benzopyrone

7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-2-benzopyrone

C25H15N3O2 (389.1164)


   
   

Cefprozil IMpurity C

Cefprozil IMpurity C

C18H19N3O5S (389.1045)


   

TAGIT

(3,4,5-Triacetyloxy-6-isothiocyanatooxan-2-yl)methyl acetate

C15H19NO9S (389.078)


   

2-Methyl-2-propanyl 4-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-1-pip eridinecarboxylate

2-Methyl-2-propanyl 4-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-1-pip eridinecarboxylate

C14H20BrN3O3S (389.0409)


   
   

Benzenebutanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-, dipotassium salt

Benzenebutanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-5-(sulfooxy)-, dipotassium salt

C13H18KO9S (389.0309)


   

Vanadium,oxobis(1-phenyl-1,3-butanedionato-kO1,kO3)-

Vanadium,oxobis(1-phenyl-1,3-butanedionato-kO1,kO3)-

C20H18O5V (389.0594)


   

4-METHYL-2-(TRIBUTYLSTANNYL)THIAZOLE

4-METHYL-2-(TRIBUTYLSTANNYL)THIAZOLE

C16H31NSSn (389.1199)


   

((Methylimino)diethylene)bis(ethyldimethylammonium bromide)

((Methylimino)diethylene)bis(ethyldimethylammonium bromide)

C13H33Br2N3 (389.1041)


   

Cipargamin

Cipargamin

C19H14Cl2FN3O (389.0498)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   
   

Indeglitazar

Indeglitazar

C19H19NO6S (389.0933)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Indeglitazar (PPM 204) is an orally available PPAR pan-agonist for all three PPARα, PPARδ and PPARγ[1].

   

Metoclopramide dihydrochloride monohydrate

Metoclopramide dihydrochloride monohydrate

C14H26Cl3N3O3 (389.104)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-hydroxy-N-sulfooxypent-4-enimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-hydroxy-N-sulfooxypent-4-enimidothioate

C11H19NO10S2 (389.045)


   

Acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester

Acetic acid [4-[[3-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]anilino]-oxomethyl]phenyl] ester

C21H15N3O5 (389.1012)


   

N-[2-(3,4-Dihydro-3-oxo-2-quinoxalinyl)-4-(1-methylethyl)phenyl]-2-thiophenecarboxamide

N-[2-(3,4-Dihydro-3-oxo-2-quinoxalinyl)-4-(1-methylethyl)phenyl]-2-thiophenecarboxamide

C22H19N3O2S (389.1198)


   

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

C19H14F3N3O3 (389.0987)


   
   

N-[5-amino-4-(1,3-benzothiazol-2-yl)-3-oxo-2H-pyrrol-1-yl]-1H-indole-3-carboxamide

N-[5-amino-4-(1,3-benzothiazol-2-yl)-3-oxo-2H-pyrrol-1-yl]-1H-indole-3-carboxamide

C20H15N5O2S (389.0946)


   

4-Chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol

4-Chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol

C19H20ClN3O4 (389.1142)


   

Adenosine-5-monophosphate-propyl ester

Adenosine-5-monophosphate-propyl ester

C13H20N5O7P (389.11)


   

N-Hydroxy-4-(methyl{[5-(2-pyridinyl)-2-thienyl]sulfonyl}amino)benzamide

N-Hydroxy-4-(methyl{[5-(2-pyridinyl)-2-thienyl]sulfonyl}amino)benzamide

C17H15N3O4S2 (389.0504)


   

2-[(1r)-1-Carboxy-2-Naphthalen-1-Ylethyl]-1,3-Dioxo-2,3-Dihydro-1h-Isoindole-5-Carboxylic Acid

2-[(1r)-1-Carboxy-2-Naphthalen-1-Ylethyl]-1,3-Dioxo-2,3-Dihydro-1h-Isoindole-5-Carboxylic Acid

C22H15NO6 (389.0899)


   

N-[(2-Amino-6-methylpyrimidin-4-YL)methyl]-3-{[(E)-(2-oxodihydrofuran-3(2H)-ylidene)methyl]amino}benzenesulfonamide

N-[(2-Amino-6-methylpyrimidin-4-YL)methyl]-3-{[(E)-(2-oxodihydrofuran-3(2H)-ylidene)methyl]amino}benzenesulfonamide

C17H19N5O4S (389.1158)


   

Adenosine phosphonoacetic acid

Adenosine phosphonoacetic acid

C12H16N5O8P (389.0736)


   

Guanosine-2,3-O-ethylidenephosphonate

Guanosine-2,3-O-ethylidenephosphonate

C12H16N5O8P (389.0736)


   

N-[4-(2-Chlorophenyl)-1,3-Dioxo-1,2,3,6-Tetrahydropyrrolo[3,4-C]carbazol-9-Yl]formamide

N-[4-(2-Chlorophenyl)-1,3-Dioxo-1,2,3,6-Tetrahydropyrrolo[3,4-C]carbazol-9-Yl]formamide

C21H12ClN3O3 (389.0567)


   

(6s)-1-Chloro-3-[(4-Fluorobenzyl)oxy]-6-(Pyrrolidin-1-Ylcarbonyl)pyrrolo[1,2-A]pyrazin-4(6h)-One

(6s)-1-Chloro-3-[(4-Fluorobenzyl)oxy]-6-(Pyrrolidin-1-Ylcarbonyl)pyrrolo[1,2-A]pyrazin-4(6h)-One

C19H17ClFN3O3 (389.0942)


   

(2e,3e)-4-(2-Aminoethoxy)-2-[({3-Hydroxy-2-Methyl-5-[(Phosphonooxy)methyl]pyridin-4-Yl}methyl)imino]but-3-Enoic Acid

(2e,3e)-4-(2-Aminoethoxy)-2-[({3-Hydroxy-2-Methyl-5-[(Phosphonooxy)methyl]pyridin-4-Yl}methyl)imino]but-3-Enoic Acid

C14H20N3O8P (389.0988)


   

Indibulin

Indibulin

C22H16ClN3O2 (389.0931)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

R-2-Hydroxy-3-butenyl glucosinolate

R-2-Hydroxy-3-butenyl glucosinolate

C11H19NO10S2 (389.045)


   

Carbamoyl adenylate(1-)

Carbamoyl adenylate(1-)

C11H14N6O8P- (389.0611)


   

(2S,4S,5R,6R)-5-acetamido-6-[(1R,2R)-1,2-dihydroxy-3-phosphonooxypropyl]-2,4-dihydroxyoxane-2-carboxylic acid

(2S,4S,5R,6R)-5-acetamido-6-[(1R,2R)-1,2-dihydroxy-3-phosphonooxypropyl]-2,4-dihydroxyoxane-2-carboxylic acid

C11H20NO12P (389.0723)


   
   

7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C18H19N3O5S (389.1045)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(4E)-4-[2-(2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-ium-1-ylidene)ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

(4E)-4-[2-(2-carboxy-5,6-dihydroxy-2,3-dihydroindol-1-ium-1-ylidene)ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

C18H17N2O8+ (389.0985)


   

Brisoral

(Z)-Cefprozil

C18H19N3O5S (389.1045)


A semisynthetic, second-generation cephalosporin, with prop-1-enyl and (R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used to treat bronchitis as well as ear, skin and other bacterial infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(1,3-benzothiazol-2-ylthio)methyl]-4-triazolecarboxylic acid methyl ester

1-(4-Amino-1,2,5-oxadiazol-3-yl)-5-[(1,3-benzothiazol-2-ylthio)methyl]-4-triazolecarboxylic acid methyl ester

C14H11N7O3S2 (389.0365)


   

6-(1,3-benzodioxol-5-yl)-N-ethyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-ethyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C22H19N3O2S (389.1198)


   

8-Nitroguanosine 3,5-cyclic monophosphate(1-)

8-Nitroguanosine 3,5-cyclic monophosphate(1-)

C10H10N6O9P- (389.0247)


   

1-S-[(3S)-3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(3S)-3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

C11H19NO10S2 (389.045)


   

2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamide

2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-(3-methoxyphenyl)benzamide

C22H16FN3O3 (389.1176)


   

N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline

N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline

C20H18F2NO3P (389.0992)


   

2-chloro-N-[3-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-oxopropyl]benzamide

2-chloro-N-[3-[(6-methoxy-1,3-benzothiazol-2-yl)amino]-3-oxopropyl]benzamide

C18H16ClN3O3S (389.0601)


   

4-(2-fluorophenyl)-5-(furan-2-ylmethyl)-3-(2-hydroxyphenyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one

4-(2-fluorophenyl)-5-(furan-2-ylmethyl)-3-(2-hydroxyphenyl)-4,5-dihydropyrrolo[3,4-c]pyrazol-6(2H)-one

C22H16FN3O3 (389.1176)


   

2-[acetyl(2-furanylmethyl)amino]-N-(4-chlorophenyl)-5-methyl-4-thiazolecarboxamide

2-[acetyl(2-furanylmethyl)amino]-N-(4-chlorophenyl)-5-methyl-4-thiazolecarboxamide

C18H16ClN3O3S (389.0601)


   

N-(1,3-benzodioxol-5-ylmethyl)-6-(2-chlorophenyl)-4-quinazolinamine

N-(1,3-benzodioxol-5-ylmethyl)-6-(2-chlorophenyl)-4-quinazolinamine

C22H16ClN3O2 (389.0931)


   

6-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine

6-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-[(4-methyl-2-thiophenyl)methyl]-4-quinazolinamine

C22H19N3O2S (389.1198)


   

2-[(1,5-diphenyl-2-imidazolyl)thio]-N-(2-furanylmethyl)acetamide

2-[(1,5-diphenyl-2-imidazolyl)thio]-N-(2-furanylmethyl)acetamide

C22H19N3O2S (389.1198)


   

2-(4-chlorophenyl)-N-[[2-(4-morpholinyl)anilino]-sulfanylidenemethyl]acetamide

2-(4-chlorophenyl)-N-[[2-(4-morpholinyl)anilino]-sulfanylidenemethyl]acetamide

C19H20ClN3O2S (389.0965)


   

Acetic acid [4-[2-(4-sulfamoylanilino)-4-thiazolyl]phenyl] ester

Acetic acid [4-[2-(4-sulfamoylanilino)-4-thiazolyl]phenyl] ester

C17H15N3O4S2 (389.0504)


   

4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide dihydrochloride monohydrate

4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide dihydrochloride monohydrate

C14H26Cl3N3O3 (389.104)


   

2-Chloro-N-[(E)-(5-morpholin-4-ylthiophen-2-yl)methylideneamino]-5-(trifluoromethyl)aniline

2-Chloro-N-[(E)-(5-morpholin-4-ylthiophen-2-yl)methylideneamino]-5-(trifluoromethyl)aniline

C16H15ClF3N3OS (389.0576)


   

1-S-[3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

1-S-[3-hydroxy-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

C11H19NO10S2 (389.045)


   
   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3R)-3-hydroxy-N-sulfooxypent-4-enimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3R)-3-hydroxy-N-sulfooxypent-4-enimidothioate

C11H19NO10S2 (389.045)


   

2-[2-(1,3-Benzothiazol-2-ylsulfonyl)ethylthio]-4,6-dimethyl-3-pyridinecarbonitrile

2-[2-(1,3-Benzothiazol-2-ylsulfonyl)ethylthio]-4,6-dimethyl-3-pyridinecarbonitrile

C17H15N3O2S3 (389.0326)


   

Ethyl 4-{[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino}benzoate

Ethyl 4-{[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]amino}benzoate

C17H12F5NO4 (389.0686)


   
   
   
   
   
   

1-S-[(1Z)-N-(sulfooxy)hexanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(1Z)-N-(sulfooxy)hexanimidoyl]-1-thio-beta-D-glucopyranose

C12H23NO9S2 (389.0814)


   

1-S-[(1Z)-3-methyl-N-(sulfooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(1Z)-3-methyl-N-(sulfooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose

C12H23NO9S2 (389.0814)


   

2-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(imidazo[1,2-a]pyrimidin-3-yl)ethanone

2-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(imidazo[1,2-a]pyrimidin-3-yl)ethanone

C18H17Cl2N5O (389.081)


   

[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3S)-3-hydroxy-N-sulfooxypent-4-enimidothioate

[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1Z,3S)-3-hydroxy-N-sulfooxypent-4-enimidothioate

C11H19NO10S2 (389.045)


   

Progoitrin

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (3R)-3-hydroxy-N-sulfooxy-pent-4-enimidothioate

C11H19NO10S2 (389.045)


Progoitrin is the stereoisomer of xi-progoitrin that has R at the carbon bearing the allylic hydroxy group. It has a role as a plant metabolite. It is a conjugate acid of a progoitrin(1-). Progoitrin is a natural product found in Isatis tinctoria and Brassica oleracea with data available. The stereoisomer of xi-progoitrin that has R at the carbon bearing the allylic hydroxy group. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2]. Progoitrin is the dominant glucosinolate in incriminated crops. Antithyroid activity[1][2].

   

N-Acetylneuraminic acid 9-phosphate

N-Acetylneuraminic acid 9-phosphate

C11H20NO12P (389.0723)


   
   

6-FITC

Fluorescein-5-isothiocyanate

C21H11NO5S (389.0358)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins

   

xi-Progoitrin

xi-Progoitrin

C11H19NO10S2 (389.045)


A hydroxy-alkenylglucosinolic acid in which a 3-hydroxybut-1-en-4-yl group is attached to the carbon of the oxime sulfate moiety.

   

2-methylbutylglucosinolic acid

2-methylbutylglucosinolic acid

C12H23NO9S2 (389.0814)


An alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-methyl-N-(sulfooxy)pentanimidoyl group at the anomeric sulfur.

   

5-Acetylphosphoadenosine

5-Acetylphosphoadenosine

C12H16N5O8P (389.0736)


   

pentylglucosinolic acid

pentylglucosinolic acid

C12H23NO9S2 (389.0814)


An alkylglucosinolic acid that has pentyl as the alkyl group.

   

(Rac)-Razpipadon

(Rac)-Razpipadon

C19H17F2N3O4 (389.1187)


PW0464, a nanomolar potent complete G protein biased ligand, is a noncatechol D1R agonist, with an EC50 of 5.8 nM (Gs-cAMP)[1].

   

A-61603

A-61603

C14H20BrN3O3S (389.0409)


A-61603 is a selective α1A-adrenergic receptor agonist[1]. A-61603 increases the frequency of spontaneous Ca2+ transients in rat ventricular myocytes in vitro[2].

   

VU6000918

VU6000918

C18H17F2N5OS (389.1122)


VU6000918 is a muscarinic acetylcholine (M4) positive allosteric modulator, with an EC50 of 19 nM for hM4[1].

   

methyl (2s)-3-[(1z,12z)-13-bromo-13-chlorotrideca-1,12-dien-1-yl]-2h-azirine-2-carboxylate

methyl (2s)-3-[(1z,12z)-13-bromo-13-chlorotrideca-1,12-dien-1-yl]-2h-azirine-2-carboxylate

C17H25BrClNO2 (389.0757)


   

[(z)-[(3r)-3-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(z)-[(3r)-3-hydroxy-1-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.045)


   

n-[2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enamide

n-[2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enamide

C18H16BrNO4 (389.0263)


   

methyl 3-(13-bromo-13-chlorotrideca-1,12-dien-1-yl)-2h-azirine-2-carboxylate

methyl 3-(13-bromo-13-chlorotrideca-1,12-dien-1-yl)-2h-azirine-2-carboxylate

C17H25BrClNO2 (389.0757)


   

[(e)-[(3s)-3-hydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(e)-[(3s)-3-hydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.045)


   

[(3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

[(3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

C11H19NO10S2 (389.045)


   

(e,2z)-n-[(1e)-2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enimidic acid

(e,2z)-n-[(1e)-2-(3-bromo-4-hydroxyphenyl)ethenyl]-3-(4-hydroxyphenyl)-2-methoxyprop-2-enimidic acid

C18H16BrNO4 (389.0263)


   

2-{[(5-amino-5-carboxy-1-hydroxypentylidene)amino](carboxy)methyl}-5-formyl-3,6-dihydro-2h-1,3-thiazine-4-carboxylic acid

2-{[(5-amino-5-carboxy-1-hydroxypentylidene)amino](carboxy)methyl}-5-formyl-3,6-dihydro-2h-1,3-thiazine-4-carboxylic acid

C14H19N3O8S (389.0893)


   

2-{1-acetyl-5-hydroxy-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzoic acid

2-{1-acetyl-5-hydroxy-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl}benzoic acid

C22H15NO6 (389.0899)


   

(2s)-2-carboxy-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

(2s)-2-carboxy-1-{2-[(2s)-2,6-dicarboxy-2,3-dihydro-1h-pyridin-4-ylidene]ethylidene}-5,6-dihydroxy-2,3-dihydro-1h-1λ⁵-indol-1-ylium

[C18H17N2O8]+ (389.0985)


   

(4s,5r,6r)-6-[(1r,2r)-1,2-dihydroxy-3-(phosphonooxy)propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

(4s,5r,6r)-6-[(1r,2r)-1,2-dihydroxy-3-(phosphonooxy)propyl]-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

C11H20NO12P (389.0723)


   

[(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

[(3-hydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene)amino]oxysulfonic acid

C11H19NO10S2 (389.045)


   

4-chloro-2-(4,5-dichloro-1h-pyrrole-3-carbonyl)-6-hexylbenzene-1,3-diol

4-chloro-2-(4,5-dichloro-1h-pyrrole-3-carbonyl)-6-hexylbenzene-1,3-diol

C17H18Cl3NO3 (389.0352)


   

[(z)-[(3r)-3-hydroxy-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(z)-[(3r)-3-hydroxy-1-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.045)


   

1-methyl-18-oxa-7,10,11-triazahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6,14,17(24),19-hexaene-5,12,16,21-tetrone

1-methyl-18-oxa-7,10,11-triazahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6,14,17(24),19-hexaene-5,12,16,21-tetrone

C21H15N3O5 (389.1012)


   

[(e)-[(3r)-3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(e)-[(3r)-3-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C11H19NO10S2 (389.045)